RxDoctor Payments Data

Tyler McAllister, DPM

Foot & Ankle Surgery · Las Vegas, NVNPI 1427542513

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,382 of the $4,229 with a category attached, or 80.0%. 15 manufacturers reported payments, led by Integra Lifesciences Corporation at 39.3% of the total. Reporting peaked in 2019 at $2,527 and has fallen 86.3% since, to $346 in 2025. That places this record below the midpoint for foot & ankle surgery clinicians in NV, where the typical reported total is $3,921.

$4,229in general payments, 2019–2025

Across 145 payments — averaging $29.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Integra Lifesciences Corporation$2K
  • Stryker$945
  • Zimmer Biomet$694
  • Smith+Nephew$378
  • Lifenet Health$141
  • Acera Surgical, Inc.$135
  • plus $273 from 9 others

What the payments were for

  • Travel & lodging$67216%
  • Food & beverage$3,38280%
  • Education$601%
  • Other$1153%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,229 in reported general payments places this provider in the 50th percentile of 84 foot & ankle surgery providers in Nevada.

See all foot & ankle surgery providers in Nevada

Medicare billing

Part B allowed, 2024
$39,213
Medicare patients
153
Services billed
535

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciclopirox13$399
Gabapentin18$266
Terbinafine Hcl12$187
Meloxicam27$40

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Las Vegas

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →